[Sarcomas of soft tissue in the adult. Therapeutical indications].

Abstract:

:Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non-involved tissue, and as consequence, resulting dysfunction, can be reduced by properly planned postoperative radiotherapy and chemotherapy. Moreover, surgery may be easier, following preoperative radiotherapy or chemotherapy, which may also allow secondary excision of a primarily inoperable tumor. For the treatment of the micrometastatic disease, the efficacy of adjuvant chemotherapy has to be confirmed by further studies; some results published to date are encouraging. Thus, treatment of soft-tissue sarcomas remains difficult, but important advances are to be expected in the next few years. A multidisciplinary approach is necessary, involving not only surgeons, radiotherapists and medical oncologists, but also radiologists and pathologists.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Bui NB

subject

Has Abstract

pub_date

1988-01-01 00:00:00

pages

493-503

issue

5

eissn

0007-4551

issn

1769-6917

journal_volume

75

pub_type

杂志文章
  • [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].

    abstract::Estrogen receptor determinations were performed on 241 cytosols from 160 breast cancer tumors, using both dextran coated charcoal method (D.C.C.) and monoclonal antibodies (Abbott's ER-EIA kit) in order to compare the two methods, and to evaluate the clinical usefulness of this new immunological simplified assay. Intr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J,Lechevrel C,Martin PM,Roussel G

    更新日期:1985-01-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Treatment of chronic myeloid leukemia in 2007].

    abstract::The treatment of chronic myeloid leukemia (CML) has considerably evolved since imatinib mesylate has been introduced as a new therapeutic weapon for this disease. The 5-year updated results of the IRIS study confirmed that imatinib mesylate is the best first line therapy for chronic phase CML with an overall survival ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Labussière H,Hayette S,Tigaud I,Michallet M,Nicolini FE

    更新日期:2007-10-01 00:00:00

  • [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].

    abstract::In our hospital, most of the patients with a cancer received palliative chemotherapy. Then, we wanted to know in which conditions these therapies were realised and most specially for patients with lung cancer. We noted the stage of the disease at the diagnosis, the median survival duration after diagnosis and the medi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Demange C,Thiébaux I

    更新日期:2003-03-01 00:00:00

  • [Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example].

    abstract::Paclitaxel is often used as an adjuvant antineoplastic agent. However, very little data is available in literature on its potential genotoxicity on healthy human cells. Our objective is to study the potential in vitro genotoxicity of paclitaxel, by using the cytokinesis-blocked micronucleus assay in combination with f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Digue L,Orsière T,Baciuchka-Palmaro M,Duffaud F,Pompili J,Favre R,Botta A

    更新日期:2002-10-01 00:00:00

  • [Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the c...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2016.09.005

    authors: Dubois V,Brignier A,Elsermans V,Gagne K,Kennel A,Pedron B,Picard C,Ravinet A,Varlet P,Cesbron A,Delbos F,Yakoub-Agha I,Loiseau P

    更新日期:2016-11-01 00:00:00

  • [Ataxia telangiectasia: what impact in clinical oncology?].

    abstract::Ataxia telangiectasia (AT) is a hereditary disease transmitted in a recessive mode and characterized by chromosomal instability and radiosensitivity. AT patients have a 100-fold higher risk of cancer than the general population. Although AT is a rare disease of which the frequency has been estimated to be 1/40,000, th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Stoppa-Lyonnet D,Aurias A

    更新日期:1992-01-01 00:00:00

  • [Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].

    abstract::Doxifluridine, a new fluorouracil analog with a low myelosuppressive effect, has recently been subject to various disease-oriented, Phase II trials. For the present evaluation of drug tolerance, the Phase II data of 114 patients having received 376 doxifluridine cycles has been used. The treatment cycles consisted of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Winkelmann JJ,Alberto P,Mermillod B

    更新日期:1990-01-01 00:00:00

  • Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France).

    abstract::This survey, conducted in region Rhône-Alpes (France), aims to assess some data in thoracic oncology practice including availability of specialized equipments. This study is based on a questionnaire mailed to oncologists and pulmonologists in the region. Of 401 questionnaires, the response rate was 56%. Responses of 7...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1366

    authors: Couraud S,Fournel P,Moro-Sibilot D,Pérol M,Souquet PJ

    更新日期:2011-06-09 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • Utilisation des inhibiteurs de PD-1 dans les hémopathies lymphoïdes.

    abstract::ANTI-PD-1 ANTIBODIES THERAPEUTIC USE IN LYMPHOID NEOPLASMS: Immune checkpoints blockade is under investigation in oncology, and has demonstrated its clinical efficacy. In hematology, immune checkpoints blockade is in earlier stages of development, but there are strong evidences of PD-1 blockade anti-tumor efficacy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30374-5

    authors: Bounaix L,Bendouda M,Bay JO,Lemal R

    更新日期:2016-11-01 00:00:00

  • [Aprepitant for the prevention of cisplatine induced nausea and vomiting: an observational study].

    abstract::Aprepitant is actually recommended in the prevention of nausea and vomiting induced by high emetic risk chemotherapy using cisplatin. We performed an observational prospective study on 101 patients evaluating the efficacy of aprepitant in the clinical conditions of use of cisplatin, out of context of clinical trial. W...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0819

    authors: Galy G,Labidi SI,Tissier F,Combes JD,Auger A,Favier B,Latour JF

    更新日期:2009-02-01 00:00:00

  • [Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis].

    abstract::The main complication of totally implantable venous access devices is deep venous thrombosis on catheter. It may dramatically reduce the already limited venous capacity of patients undergoing chemotherapy and obturate catheters, causing pulmonary embolism or functional disorders. These thromboses usually involve veins...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pucheu A,Dierhas M,Leduc B,Sillet-Bach I,Lefort S,Assaf W,Pucheu M

    更新日期:1996-04-01 00:00:00

  • [WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods].

    abstract::The publication of the new WHO classification of head and neck tumours in 2017 brought major modifications. Especially, a new chapter is dedicated to the oropharynx, focusing on the description of squamous cell carcinoma induced by the virus Human Papilloma Virus (HPV), and new entities of tumors are described in nasa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.004

    authors: Sarradin V,Siegfried A,Uro-Coste E,Delord JP

    更新日期:2018-06-01 00:00:00

  • [Access to fertility preservation for adolescents and young adults aged 15 to 24 years with cancers in Auvergne, France].

    abstract:INTRODUCTION:Cancers of adolescents and young adults have particular epidemiological specificities. The improvement in their survival should be accompanied by an increased consideration of the treatments' side effects, among which the potential decrease in fertility. The objective of the study was to describe the acces...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.03.013

    authors: Grèze V,Mechdoud S,Vorilhon S,Isfan F,Rouel N,Chaput L,Brugnon F,Kanold J

    更新日期:2020-01-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Consultations in oncological supportive care mono-, multi-, ou interdisciplinary: What should we favour?].

    abstract::According to the point 7.6 and 7.7 of the Cancer Plan 2014, all cancer patients should have access to supportive care. Indeed, the supportive care consultation in oncology is an important tool for the symptom management of cancer patients at all times of treatment. This consultation can be mono-disciplinary or multi-d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.04.019

    authors: Garnier SR,Pelletti C,Quenard C,Vallet F,Lemoine P,Guastella V,Rhondali W

    更新日期:2015-09-01 00:00:00

  • [Rational choice of a diagnostic test for the detection of bone metastases in breast cancer as a function of prevalence (based on the Bayes theorem)].

    abstract::Since 1976 to 1978 inclusive, 465 patients with primary breast cancers underwent whole body analogical scintiscans, 456 numerical scans, and 453 were X-rayed. Ninety per cent received axillary node ablation, 62% presented adenopathies of which a third were capsular ruptures and 54% were T3 and T4. In 53 patients, the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Robillard J,Ly Van Hoa,Switzers O,Couette JE,Brune D

    更新日期:1987-01-01 00:00:00

  • [Invasive cancer of the uterine cervix in young women: retrospective study of 236 cases].

    abstract::The study of cases treated between 1970 and 1984 at the Institut Curie, in women aged 40 years and under, was undertaken in order to determine the influence of age on prognosis. The incidence of these cases was stable throughout the 15 years study period as was the very high incidence of earlier cases: 84.5%. Earlier ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fenton J,Chevret S,Asselain B,de La Rochefordière A,Mathieu G,Labib A,Durand JC,Salmon RJ

    更新日期:1990-01-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Primary prevention of colorectal cancer].

    abstract::Results from case-control studies and prospective studies suggest that diet is involved in the causation of large bowel cancer either as initiator, promoter or inhibitor of carcinogenesis. Available data are not sufficient to serve as a basis for firm specific dietary advice. In the present situation it is attractive ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faivre J,Couillault C,Belghiti C

    更新日期:1995-07-01 00:00:00

  • [Biological bases for individualising prescriptions in oncology: the germline genome].

    abstract::Sequencing the human genome brings new tools for the individualisation of cancer chemotherapy, especially thanks to the identification of polymorphisms of genes involved in anticancer drug metabolism or activity (pharmacogenetics). A few functional polymorphisms have been known for a long time (thiopurine methyltransf...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0722

    authors: Robert J,Le Morvan V

    更新日期:2008-10-01 00:00:00

  • [Hypoxia and angiogenesis].

    abstract::The presence of hypoxic regions within solid tumours is associated with a more malignant tumour phenotype and worse prognosis. To obtain a blood supply and protect against cellular damage and death, oxygen-deprived cells in tumours alter gene expression, resulting in resistance to therapy. Hypoxia is sensed at the cel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Simon JM

    更新日期:2007-07-01 00:00:00

  • Cost-effectiveness analysis for clinical procedures in oncology.

    abstract::The provision of medical care consumes resources, and the resources available for the provision of medical care are limited. Decisions are being made at many levels of the Health Care System, including providers and fiscal intermediaries, to allocate these resources. Such decisions, however, are often inconsistent wit...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weinstein MC

    更新日期:1980-01-01 00:00:00

  • [Postmastectomy pain syndrome evidence based guidelines and decision trees].

    abstract::A multidisciplinary expert group had reviewed all scientific data available of post mastectomy pain syndrome. Seventy six publications were retained and thirty evidence based diagnosis, treatment and follow-up recommendations are listed. Few of theses recommendations are classed level A. Datas analysis make possible t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:

    authors: Labrèze L,Dixmérias-Iskandar F,Monnin D,Bussières E,Delahaye E,Bernard D,Lakdja F

    更新日期:2007-03-01 00:00:00

  • [Proton therapy in soft tissue and bone sarcomas].

    abstract::Sarcomas are a common type of tumor within the pediatric population. The utilization of proton therapy as a primary attribute the ability to spare adjacent healthy tissue, therefore, proton therapy has become a preferential indication in pediatrics compared to other photon irradiation modalities. Proton therapy is als...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.05.008

    authors: Thariat J,Tessonnier T,Bonvalot S,Lerouge D,Mammar H,Bolle S,Claren A,Duffaud F,Alapetite C,Vogin G

    更新日期:2018-09-01 00:00:00

  • [Advances in adults' gliomas biology, imaging and treatment].

    abstract::A better understanding of gliomas biology is now leading to a combined histo-molecular classification of these tumors. In anaplastic gliomas ongoing studies depend on 1p/19q codeletion status and in glioblastomas on MGMT methylation status. Advanced brain tumor imaging elicits a better identification of gliomas evolut...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.1019

    authors: Ducray F,Dutertre G,Ricard D,Gontier E,Idbaih A,Massard C

    更新日期:2010-01-01 00:00:00

  • [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].

    abstract::Neuroblastoma is the most common pediatric extracranial solid cancer. Patients with metastatic disease at initial diagnosis who are greater than 18  months of age and patients with MycN amplified locoregional tumors are treated with intensive multimodal therapy. While this intensive approach has been shown to improve ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1353

    authors: Défachelles AS,Cougnenc O,Carpentier P

    更新日期:2011-05-01 00:00:00

  • [Use of complementary medicine by cancer patients in a French oncology department].

    abstract::The aims of this study was to estimate and describe the reasons of use of complementary medicine in patients with a cancer treated in a French oncology department. An anonymous questionnaire was proposed to patients during treatment or follow-up in an oncology department. It was a descriptive study over 207 questionna...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Träger-Maury S,Tournigand C,Maindrault-Goebel F,Afchain P,de Gramont A,Garcia-Larnicol ML,Gervais H,Louvet C

    更新日期:2007-11-01 00:00:00

  • [Opioid switch and change of route of administration in cancer patients treated by morphine].

    abstract::This paper reviewed the 2002 guidelines established by the National Federation of Cancer Centres. A group of experts nominated by the 3 French Societies involved in the treatment of cancer pain (AFSOS, SFAP, SFETD), established new guidelines ratios for morphine switching and/or changing of route of administration, in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2018.06.011

    authors: Michenot N,Rostaing S,Baron L,Faure S,Jovenin N,Hubault P,Delorme T,Collin E,Filbet M,Chvetzoff G,Delorme C,Minello C,Magnet M,Ammar D,Krakowski I,Poulain P

    更新日期:2018-11-01 00:00:00